Literature DB >> 21392564

In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems.

Anne T Larsen1, Philip Sassene, Anette Müllertz.   

Abstract

With the increasing interest in lipid and surfactant based drug delivery systems (LSBDDS) for oral delivery of poorly soluble drugs, the need for efficient development tools is emerging. In vitro lipolysis models, simulating the digestion in the small intestine, is a promising tool in this regard. Several different in vitro lipolysis models have been used for characterization of LSBDDS, all using porcine pancreatin as lipase source, and primarily differing in the addition scheme of calcium and the kind of bile acids employed. Both calcium and bile influence the lipolysis. Calcium have been used both as fixed addition at the beginning of the experiment and with a continuous addition during lipolysis. Both pure bile acids and crude porcine bile extract have been used. Lipolysis of LSBDDS will generate mixed micelles, as well as lamellar and hexagonal phases. These have been characterized by dynamic light scattering, cryogenic transmission electron microscopy and small angle X-ray scattering. The faith of drug during in vitro digestion of a LSBDDS is often studied by ultracentrifugation and quantification of drug in the different phases formed. Further, drug precipitated during in vitro lipolysis has been characterized by X-ray powder diffraction and polarized light microscopy.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21392564     DOI: 10.1016/j.ijpharm.2011.03.002

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  19 in total

1.  A new in vitro lipid digestion - in vivo absorption model to evaluate the mechanisms of drug absorption from lipid-based formulations.

Authors:  Matthew F Crum; Natalie L Trevaskis; Hywel D Williams; Colin W Pouton; Christopher J H Porter
Journal:  Pharm Res       Date:  2015-12-24       Impact factor: 4.200

2.  Self-assembled structures formed during lipid digestion: characterization and implications for oral lipid-based drug delivery systems.

Authors:  Stephanie Phan; Stefan Salentinig; Clive A Prestidge; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

3.  Insights into drug precipitation kinetics during in vitro digestion of a lipid-based drug delivery system using in-line raman spectroscopy and mathematical modeling.

Authors:  Cordula Stillhart; Georgios Imanidis; Martin Kuentz
Journal:  Pharm Res       Date:  2013-02-28       Impact factor: 4.200

4.  Effect of lipolysis on drug release from self-microemulsifying drug delivery systems (SMEDDS) with different core/shell drug location.

Authors:  Jianbin Zhang; Yan Lv; Shan Zhao; Bing Wang; Mingqian Tan; Hongguo Xie; Guojun Lv; Xiaojun Ma
Journal:  AAPS PharmSciTech       Date:  2014-02-20       Impact factor: 3.246

5.  In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate.

Authors:  Nicky Thomas; Katharina Richter; Thomas B Pedersen; René Holm; Anette Müllertz; Thomas Rades
Journal:  AAPS J       Date:  2014-04-02       Impact factor: 4.009

Review 6.  Lipids in the Stomach - Implications for the Evaluation of Food Effects on Oral Drug Absorption.

Authors:  Mirko Koziolek; Frédéric Carrière; Christopher J H Porter
Journal:  Pharm Res       Date:  2018-02-08       Impact factor: 4.200

7.  Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.

Authors:  Kazi Mohsin
Journal:  AAPS PharmSciTech       Date:  2012-05-01       Impact factor: 3.246

Review 8.  The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations.

Authors:  Jamal Khan; Thomas Rades; Ben Boyd
Journal:  Pharm Res       Date:  2015-11-23       Impact factor: 4.200

9.  In vitro lipolysis and intestinal transport of β-arteether-loaded lipid-based drug delivery systems.

Authors:  Patrick B Memvanga; Pierre Eloy; Eric M Gaigneaux; Véronique Préat
Journal:  Pharm Res       Date:  2013-06-06       Impact factor: 4.200

10.  Solid lipid particles for oral delivery of peptide and protein drugs II--the digestion of trilaurin protects desmopressin from proteolytic degradation.

Authors:  Philip Carsten Christophersen; Long Zhang; Anette Müllertz; Hanne Mørck Nielsen; Mingshi Yang; Huiling Mu
Journal:  Pharm Res       Date:  2014-03-13       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.